Showing results (241-250 of 295) with videos related to

Sort By:
Pageof 30
The Journal of Antimicrobial Chemotherapy|July 1, 1983
Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patientsR Ramphal, B S Kramer, K H Rand, et al.
British Journal of Obstetrics and Gynaecology|April 1, 1986
Cervical intraepithelial neoplasia treated by perilesional injection of interferonY C Choo, W H Seto, C Hsu, et al.
Archives of Gynecology|January 1, 1985
Intravaginal application of leukocyte interferon gel in the treatment of cervical intraepithelial neoplasia (CIN)Y C Choo, C Hsu, W H Seto, et al.
Acta Cytologica|March 1, 1984
Exfoliative cytology in the evaluation of interferon treatment of cervical intraepithelial neoplasiaC Hsu, Y C Choo, W H Seto, et al.
Cell Transplantation|March 7, 1998
Generation of primary peptide-specific CD8+ cytotoxic T-lymphocytes in vitro using allogeneic dendritic cellsM V Peshwa, C Benike, M Dupuis, et al.
Annals of Internal Medicine|December 28, 1999
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failedA R Zolopa, R W Shafer, A Warford, et al.
AIDS Research and Human Retroviruses|January 1, 1997
Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individualsM Dupuis, M V Peshwa, C Benike, et al.
Hepatology (Baltimore, Md.)|November 1, 1981
Dane particle DNA polymerase and HBeAg: impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver diseaseL L Andres, V K Sawhney, G H Scullard, et al.
The Journal of Infectious Diseases|December 8, 1998
Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229J M Schapiro, J Lawrence, R Speck, et al.
The Journal of Infectious Diseases|February 10, 1999
Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study GroupJ P Kleim, M Winters, A Dunkler, et al.
Pageof 30